The purpose of the invention is to provide a novel therapeutic agent for Alzheimer's disease and use thereof Provided is a therapeutic agent for Alzheimer's disease, which contains a CpG oligodeoxynucleotide structure having a brain migration and improved stability or a salt thereof as an active ingredient.